Start the conversation
Synovus Financial Corp. (SNV) completed the bulk sale of its distressed assets. The selling process was initiated on Dec 10 with an aim to reduce balance sheet risk.
Breaking News: The FDA Just Put Its "Seal of Approval" on Our Surging Medical Marijuana Biotech
Insys Therapeutics Inc. (NASDAQ: INSY) – our “War on Pain” biotech play – has given us a profit of more than 16% since we recommended the stock just two weeks ago.